# Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition

> **NCT01545479** · PHASE4 · COMPLETED · sponsor: **Instituto de Cardiologia do Rio Grande do Sul** · enrollment: 5 (actual)

## Conditions studied

- Renal Disease

## Interventions

- **DRUG:** captopril 25mg

## Key facts

- **NCT ID:** NCT01545479
- **Lead sponsor:** Instituto de Cardiologia do Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01545479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01545479, "Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01545479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*